Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer

Statins are a group of lipid-lowering drugs with pleiotropic effects that include, but are not limited to the inhibition of cholesterol synthesis resulting in a wide range of anti-inflammatory, anti-tumor, immunomodulatory, and anti-thrombotic properties. This study aimed to determine the impact of the prior to- or after breast surgery usage of statins on the tumor prognosis in breast cancer (BC) patients.

Palabras clave: EARLY BREAST CANCER PATIENTS , PROGNOSTIC FACTORS , STATINS , TUMOR EVOLUTION

Ver el registro completo

Archivos asociados

Tamaño: 3.014Mb

Formato: PDF

Solicitar

Licencia

Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Atribución-NoComercial-SinDerivadas 2.5 Argentina (CC BY-NC-ND 2.5 AR)

Identificadores

URI: http://hdl.handle.net/11336/238282

URL: https://www.sciencedirect.com/science/article/abs/pii/S1877782124000523

DOI: http://dx.doi.org/10.1016/j.canep.2024.102573

Colecciones

Articulos(IBYME)
Articulos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)

Citación

Giorello, Maria Belen; Marks, Maria Paula; Osinalde, Tiago Martín; Padin, María del Rosario; Wernicke, Alejandra; et al.; Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer; Elsevier; Cancer Epidemiology; 90; 102573; 6-2024; 1-8

Altmétricas